- Home
- AENT vs CCCC Comparison
AENT vs CCCC Comparison
Compare AENT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AENT
- CCCC
- Stock Information
- Founded
- AENT 1990
- CCCC 2015
- Country
- AENT United States
- CCCC United States
- Employees
- AENT N/A
- CCCC N/A
- Industry
- AENT Durable Goods
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- AENT Consumer Discretionary
- CCCC Health Care
- Exchange
- AENT Nasdaq
- CCCC Nasdaq
- Market Cap
- AENT 472.7M
- CCCC 396.0M
- IPO Year
- AENT N/A
- CCCC 2020
- Fundamental
- Price
- AENT $4.85
- CCCC $3.94
- Analyst Decision
- AENT
- CCCC Buy
- Analyst Count
- AENT 0
- CCCC 6
- Target Price
- AENT N/A
- CCCC $10.67
- AVG Volume (30 Days)
- AENT 139.6K
- CCCC 2.0M
- Earning Date
- AENT 02-06-2025
- CCCC 02-20-2025
- Dividend Yield
- AENT N/A
- CCCC N/A
- EPS Growth
- AENT N/A
- CCCC N/A
- EPS
- AENT 0.17
- CCCC N/A
- Revenue
- AENT $1,102,718,000.00
- CCCC $33,668,000.00
- Revenue This Year
- AENT $4.77
- CCCC $75.79
- Revenue Next Year
- AENT N/A
- CCCC N/A
- P/E Ratio
- AENT $29.27
- CCCC N/A
- Revenue Growth
- AENT N/A
- CCCC 65.45
- 52 Week Low
- AENT $1.07
- CCCC $3.38
- 52 Week High
- AENT $11.57
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- AENT 38.41
- CCCC 48.85
- Support Level
- AENT $4.54
- CCCC $3.81
- Resistance Level
- AENT $6.58
- CCCC $4.07
- Average True Range (ATR)
- AENT 1.67
- CCCC 0.28
- MACD
- AENT -0.57
- CCCC 0.05
- Stochastic Oscillator
- AENT 4.41
- CCCC 63.64
About AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.